Oct4 and Sox2 are overexpressed in human neuroblastoma and inhibited by chemotherapy

Author：

ISSN： 1021-335X

Source： Oncology Reports, Vol.28, Iss.1, 2012-01, pp. : 186-192

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Downregulation of OCT4 promotes differentiation and inhibits growth of BE (2)-C human neuroblastoma I-type cells

Oncology Reports, Vol. 29, Iss. 6, 2013-01 ,pp. : 2191-2196

Spandidos Publications

Access to resources Recommend Favorite

Hypoxia induces CD133 expression in human lung cancer cells by up-regulation of OCT3/4 and SOX2

International Journal of Oncology, Vol. 40, Iss. 1, 2012-01 ,pp. : 71-79

Spandidos Publications

Access to resources Recommend Favorite

Expression of the pluripotency markers Oct3/4, Nanog and Sox2 in human breast cancer cell lines

Oncology Letters, Vol. 4, Iss. 6, 2012-01 ,pp. : 1264-1268

Spandidos Publications

Access to resources Recommend Favorite

Microarray data analysis of neuroblastoma: Expression of SOX2 downregulates the expression of MYCN

Molecular Medicine Reports, Vol. 12, Iss. 5, 2015-01 ,pp. : 6867-6872

Spandidos Publications

Access to resources Recommend Favorite

SOX2 promotes tumorigenicity and inhibits the differentiation of I-type neuroblastoma cells

International Journal of Oncology, Vol. 46, Iss. 1, 2015-01 ,pp. : 317-323

Spandidos Publications

Access to resources Recommend Favorite